Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Okada

Showing results (561-570 of 613) with videos related to

Pageof 62
Sort By:
ESMO Open|February 17, 2026
Gut microbiome-driven modulation of the tumor immune microenvironment optimizes dual checkpoint blockade in advanced non-small-cell lung cancerY Katayama, A Fukuda, R Inoue, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 16, 2022
Subfoveal choroidal thickness after brolucizumab therapy for neovascular age-related macular degeneration: a short-term multicenter studyTamaki Tamashiro, Koji Tanaka, Kanako Itagaki, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 5, 2023
Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degenerationKeiko Kataoka, Kanako Itagaki, Nozumu Hashiya, et al.
Frontiers in Medicine|February 6, 2023
Ten-year follow-up of infliximab treatment for uveitis in Behçet disease patients: A multicenter retrospective studyMasaru Takeuchi, Yoshihiko Usui, Kenichi Namba, et al.
Eye (London, England)|October 8, 2024
Treatment regimens for optimising outcomes in patients with neovascular age-related macular degenerationKelvin Yi Chong Teo, Bora Eldem, Antonia Joussen, et al.
Scientific Reports|May 22, 2024
One-year outcomes and safety assessment of faricimab in treatment-naïve patients with neovascular age-related macular degeneration in JapanRyo Mukai, Keiko Kataoka, Koji Tanaka, et al.
The British Journal of Ophthalmology|June 27, 2020
Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemicRupesh Agrawal, Ilaria Testi, Cecilia S Lee, et al.
Journal of Ophthalmic Inflammation and Infection|May 23, 2012
Clinical spectrum of tuberculous optic neuropathyEllen J Davis, Sivakumar R Rathinam, Annabelle A Okada, et al.
American Journal of Ophthalmology|July 4, 2006
Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada diseaseRussell W Read, Fei Yu, Massimo Accorinti, et al.
Ocular Immunology and Inflammation|November 6, 2018
Association Study of <i>ARMC9</i> Gene Variants with Vogt-Koyanagi-Harada Disease in Japanese PatientsTomoko Ohno, Akira Meguro, Masaki Takeuchi, et al.
Pageof 62

Showing results (561-570 of 613) with videos related to

Sort By:
Pageof 62
ESMO Open|February 17, 2026
Gut microbiome-driven modulation of the tumor immune microenvironment optimizes dual checkpoint blockade in advanced non-small-cell lung cancerY Katayama, A Fukuda, R Inoue, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 16, 2022
Subfoveal choroidal thickness after brolucizumab therapy for neovascular age-related macular degeneration: a short-term multicenter studyTamaki Tamashiro, Koji Tanaka, Kanako Itagaki, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 5, 2023
Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degenerationKeiko Kataoka, Kanako Itagaki, Nozumu Hashiya, et al.
Frontiers in Medicine|February 6, 2023
Ten-year follow-up of infliximab treatment for uveitis in Behçet disease patients: A multicenter retrospective studyMasaru Takeuchi, Yoshihiko Usui, Kenichi Namba, et al.
Eye (London, England)|October 8, 2024
Treatment regimens for optimising outcomes in patients with neovascular age-related macular degenerationKelvin Yi Chong Teo, Bora Eldem, Antonia Joussen, et al.
Scientific Reports|May 22, 2024
One-year outcomes and safety assessment of faricimab in treatment-naïve patients with neovascular age-related macular degeneration in JapanRyo Mukai, Keiko Kataoka, Koji Tanaka, et al.
The British Journal of Ophthalmology|June 27, 2020
Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemicRupesh Agrawal, Ilaria Testi, Cecilia S Lee, et al.
Journal of Ophthalmic Inflammation and Infection|May 23, 2012
Clinical spectrum of tuberculous optic neuropathyEllen J Davis, Sivakumar R Rathinam, Annabelle A Okada, et al.
American Journal of Ophthalmology|July 4, 2006
Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada diseaseRussell W Read, Fei Yu, Massimo Accorinti, et al.
Ocular Immunology and Inflammation|November 6, 2018
Association Study of <i>ARMC9</i> Gene Variants with Vogt-Koyanagi-Harada Disease in Japanese PatientsTomoko Ohno, Akira Meguro, Masaki Takeuchi, et al.
Pageof 62